Tisagenlecleucel chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory children and young adults with acute lymphoblastic leukemia (ALL): Real world experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and cellular therapy (CT) registry Meeting Abstract
| Authors: | Grupp, S.; Hu, Z. H.; Zhang, Y.; Keating, A.; Pulsipher, M. A.; Philips, C.; Margossian, S. P.; Rosenthal, J.; Salzberg, D.; Schiff, D. E.; Yanik, G.; Curran, K. J.; Harris, A. C.; Hematti, P.; Nikiforow, S.; Steinert, P.; Yi, L.; Chawla, R.; Horowitz, M. M.; Bleickardt, E.; Pasquini, M. C. |
| Abstract Title: | Tisagenlecleucel chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory children and young adults with acute lymphoblastic leukemia (ALL): Real world experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and cellular therapy (CT) registry |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160405279 |
| DOI: | 10.1182/blood-2019-129279 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2619 -- Source: Wos |
